Lloyd-Price, J., Abu-Ali, G. & Huttenhower, C. The healthy human microbiome. Genome Med. 8, 51 (2016).
PubMed PubMed Central Google Scholar
de Steenhuijsen Piters, W. A. A., Binkowska, J. & Bogaert, D. Early life microbiota and respiratory tract infections. Cell Host Microbe 28, 223–232 (2020).
Sulaiman, I. et al. Functional lower airways genomic profiling of the microbiome to capture active microbial metabolism. Eur. Respir. J. https://doi.org/10.1183/13993003.03434-2020 (2021).
Article PubMed PubMed Central Google Scholar
Wu, B. G. et al. Episodic aspiration with oral commensals induces a MyD88-dependent, pulmonary T-helper cell type 17 response that mitigates susceptibility to Streptococcus pneumoniae. Am. J. Respir. Crit. Care Med. 203, 1099–1111 (2021).
CAS PubMed PubMed Central Google Scholar
Pattaroni, C. et al. Early-life formation of the microbial and immunological environment of the human airways. Cell Host Microbe 24, 857–865.e4 (2018).
Thorsen, J. et al. Infant airway microbiota and topical immune perturbations in the origins of childhood asthma. Nat. Commun. 10, 5001 (2019).
PubMed PubMed Central Google Scholar
Dickson, R. P. et al. Spatial variation in the healthy human lung microbiome and the adapted island model of lung biogeography. Ann. Am. Thorac. Soc. 12, 821–830 (2015).
PubMed PubMed Central Google Scholar
Charlson, E. S. et al. Topographical continuity of bacterial populations in the healthy human respiratory tract. Am. J. Respir. Crit. Care Med. 184, 957–963 (2011).
PubMed PubMed Central Google Scholar
Dickson, R. P. et al. Bacterial Topography of the Healthy Human Lower Respiratory Tract. mBio https://doi.org/10.1128/mBio.02287-16 (2017).
Article PubMed PubMed Central Google Scholar
Segal, L. N. et al. Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. Nat. Microbiol. 1, 16031 (2016).
CAS PubMed PubMed Central Google Scholar
Huang, Y. J. et al. The airway microbiome in patients with severe asthma: associations with disease features and severity. J. Allergy Clin. Immunol. 136, 874–884 (2015).
PubMed PubMed Central Google Scholar
Dickson, R. P. et al. The lung microbiota of healthy mice are highly variable, cluster by environment, and reflect variation in baseline lung innate immunity. Am. J. Respir. Crit. Care Med. https://doi.org/10.1164/rccm.201711-2180OC (2018).
Article PubMed PubMed Central Google Scholar
Segal, L. N. et al. Anaerobic bacterial fermentation products increase tuberculosis risk in antiretroviral-drug-treated HIV patients. Cell Host Microbe 21, 530–537.e4 (2017).
CAS PubMed PubMed Central Google Scholar
Erb-Downward, J. R. et al. Analysis of the lung microbiome in the “healthy” smoker and in COPD. PLoS One 6, e16384 (2011).
CAS PubMed PubMed Central Google Scholar
Dickson, R. P., Erb-Downward, J. R. & Huffnagle, G. B. The role of the bacterial microbiome in lung disease. Expert Rev. Respir. Med. 7, 245–257 (2013).
CAS PubMed PubMed Central Google Scholar
Garcia-Nuñez, M. et al. Severity-related changes of bronchial microbiome in chronic obstructive pulmonary disease. J. Clin. Microbiol. 52, 4217–4223 (2014).
PubMed PubMed Central Google Scholar
Tsay, J. J. et al. Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer. Am. J. Respir. Crit. Care Med. 198, 1188–1198 (2018).
CAS PubMed PubMed Central Google Scholar
Gustafson, A. M. et al. Airway PI3K pathway activation is an early and reversible event in lung cancer development. Sci. Transl. Med. 2, 26ra25 (2010).
PubMed PubMed Central Google Scholar
Sethi, S., Maloney, J., Grove, L., Wrona, C. & Berenson, C. S. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173, 991–998 (2006).
PubMed PubMed Central Google Scholar
Soler, N. et al. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur. Respir. J. 14, 1015–1022 (1999).
Bresser, P., Out, T. A., van Alphen, L., Jansen, H. M. & Lutter, R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 162, 947–952 (2000).
Parameswaran, G. I., Wrona, C. T., Murphy, T. F. & Sethi, S. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease. BMC Infect. Dis. 9, 178 (2009).
PubMed PubMed Central Google Scholar
Rangelov, K. & Sethi, S. Role of infections. Clin. Chest Med. 35, 87–100 (2014).
PubMed PubMed Central Google Scholar
Morris, A. et al. Comparison of the respiratory microbiome in healthy nonsmokers and smokers. Am. J. Respir. Crit. Care Med. 187, 1067–1075 (2013).
PubMed PubMed Central Google Scholar
Segal, L. N. et al. Enrichment of lung microbiome with supraglottic taxa is associated with increased pulmonary inflammation. Microbiome 1, 19 (2013).
PubMed PubMed Central Google Scholar
Opron, K. et al. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. NPJ Biofilms Microbiomes 7, 14 (2021).
PubMed PubMed Central Google Scholar
Morris, A. et al. Longitudinal analysis of the lung microbiota of cynomolgous macaques during long-term SHIV infection. Microbiome 4, 38 (2016).
PubMed PubMed Central Google Scholar
Sze, M. A. et al. The lung tissue microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 185, 1073–1080 (2012).
PubMed PubMed Central Google Scholar
Pragman, A. A., Kim, H. B., Reilly, C. S., Wendt, C. & Isaacson, R. E. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLoS One 7, e47305 (2012).
CAS PubMed PubMed Central Google Scholar
Dicker, A. J. et al. The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease. J. Allergy Clin. Immunol. https://doi.org/10.1016/j.jaci.2020.02.040 (2020).
Wang, Z. et al. Inflammatory endotype-associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis. Am. J. Respir. Crit. Care Med. 203, 1488–1502 (2021).
CAS PubMed PubMed Central Google Scholar
Tufvesson, E., Bjermer, L. & Ekberg, M. Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation. Int. J. Chron. Obstruct. Pulmon. Dis. 10, 881–889 (2015).
PubMed PubMed Central Google Scholar
Sze, M. A. et al. The host response to the lung microbiome in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. https://doi.org/10.1164/rccm.201502-0223OC (2015).
Article PubMed PubMed Central Google Scholar
Cabello, H. et al. Bacterial colonization of distal airways in healthy subjects and chronic lung disease: a bronchoscopic study. Eur. Respir. J. 10, 1137–1144 (1997).
Monso, E. et al. Risk factors for lower airway bacterial colonization in chronic bronchitis. Eur. Respir. J. 13, 338–342 (1999).
Teo, S. M. et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe 17, 704–715 (2015).
CAS PubMed PubMed Central Google Scholar
Teo, S. M. et al. Airway microbiota dynamics uncover a critical window for interplay of pathogenic bacteria and allergy in childhood respiratory disease. Cell Host Microbe 24, 341–352.e5 (2018).
CAS PubMed PubMed Central Google Scholar
Bosch, A. et al. Maturation of the infant respiratory microbiota, environmental drivers, and health consequences. a prospective cohort study. Am. J. Respir. Crit. Care Med. 196, 1582–1590 (2017).
Zhou, Y. et al. The upper-airway microbiota and loss of asthma control among asthmatic children. Nat. Commun. 10, 5714 (2019).
CAS PubMed PubMed Central Google Scholar
Huang, Y. J. et al. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma. J. Allergy Clin. Immunol. 127, 372–381 (2011).
Hudey, S. N., Ledford, D. K. & Cardet, J. C. Mechanisms of non-type 2 asthma. Curr. Opin. Immunol. 66, 123–128 (2020).
CAS PubMed PubMed Central Google Scholar
O’Dwyer, D. N. et al. Lung microbiota contribute to pulmonary inflammation and disease progression in pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 199, 1127–1138 (2019).
PubMed PubMed Central Google Scholar
Molyneaux, P. L. et al. The role of bacteria in the pathogenesis and progression of idiopathic pulmon
留言 (0)